,11.,House Committee on Oversight and Reform (2020) Subcommittee,30.,"Havers, F.P. et al. (2020) Seroprevalence of antibodies to"
0,,on Economic and Consumer Policy COVID-19 Antibody Testing:,,"SARS-CoV-2 in 10 sites in the United States, March 23-May"
1,,"uses, abuses, limitations, and the federal response. Published on-",,"12, 2020. JAMA Intern. Med. Published online July 21, 2020."
2,,"line June 9, 2020. https://oversight.house.gov/legislation/briefings/",,https://doi.org/10.1001/jamainternmed.2020.4130
3,,subcommittee-on-economic-and-consumer-policy-covid-19-anti-,31.0,"Aleccia, J. and Barry-Jester, A.M. (2020) Hype collides with"
4,,body-testing-uses,,science as FDA tries to rein in ‘Wild West’ of COVID blood
5,12.0,Subcommittee Staff (2020) Preliminary findings of the,,"tests. Kaiser Health News. Published online June 3, 2020."
6,,subcommittee’s coronavirus antibody testing investigation.,,https://khn.org/news/hype-collides-with-science-as-fda-tries-
7,,"April 24, 2020. https://oversight.house.gov/sites/democrats.",,to-rein-in-wild-west-of-covid-blood-tests/
8,,oversight.house.gov/files/ECP%20Staff%20Report%20on%,32.0,"Tillett, R.L. et al. (2020) Genomic evidence for reinfection with"
9,,20Preliminary%20Findings%20of%20the%20Subcommittee,,SARS-CoV-2: a case study. Lancet Infect. Dis. Published on-
10,,%E2%80%99s%20Coronavirus%20Antibody%20Testing%,,"line October 12, 2020. https://doi.org/10.1016/S1473-3099"
11,,20Investigation.pdf,,(20)30764-7
12,13.0,"Food, U.S. and Administration, Drug (2020) Independent eval-",33.0,US Food and Drug Administration (2020) Serology template for
13,,uations of COVID-19 serological tests. openFDA. https://open.,,commercial manufacturers. FDA In Vitro Diagnostics EUAs
14,,fda.gov/apis/device/covid19serology/,,https://www.fda.gov/media/137698/download
15,14.0,"Tuzman, K.T. et al. (2020) NCI takes lead on serological test",34.0,"Kobokovich, A. et al. (2020) Global progress on COVID-19"
16,,validation as cancer center joins COVID-19 fight. BioCentury.,,serology-based testing. Johns Hopkins Center for Health
17,,"Published online April 9, 2020. https://www.biocentury.com/",,"Security. Published online April 17, 2020. https://www."
18,,article/304874,,centerforhealthsecurity.org/resources/COVID-19/serology/
19,15.0,"Kirkpatrick, D.D. and Bradley, J. (2020) U.K. paid $20 million",,Serology-based-tests-for-COVID-19.html
20,,for new coronavirus tests. They didn’t work. New York Times.,35.0,"Long, Q.-X. et al. (2020) Clinical and immunological assess-"
21,,"Published online April 16, 2020. https://www.nytimes.com/",,ment of asymptomatic SARS-CoV-2 infections. Nat. Med.
22,,2020/04/16/world/europe/coronavirus-antibody-test-uk.html,,"26, 1200–1204"
23,16.0,"Emanuel, E.J. et al. (2020) Fair allocation of scarce medical re-",36.0,"Whitman, J.D. et al. (2020) Evaluation of SARS-CoV-2 serology"
24,,"sources in the time of Covid-19. N. Engl. J. Med. 382,",,assays reveals a range of test performance. Nat. Biotechnol.
25,,2049–2055,,"38, 1174–1183"
26,17.0,"Vakharia, K. (2020) The right to know: ethical implications of",37.0,"Haugh, T. and Bedi, S. (2020) Just because you test positive"
27,,antibody testing for healthcare workers and overlooked socie-,,for antibodies doesn’t mean you have them. New York
28,,"tal implications. J. Med. Ethics. Published online June 3, 2020.",,"Times. Published online May 13, 2020. https://www.nytimes."
29,,https://doi.org/10.1136/medethics-2020-106467,,com/2020/05/13/opinion/antibody-test-accuracy.html
30,18.0,US Equal Employment Opportunity Commission (2020),38.0,Cellex (2020) Cellex qSARS-CoV-2 IgG/IgM Rapid Test
31,,"What you should know about COVID-19 and the ADA, the",,[instructions for use]. https://www.fda.gov/media/136625/
32,,"Rehabilitation Act, and other EEO laws. https://www.eeoc.",,download
33,,gov/wysk/what-you-should-know-about-covid-19-and-ada-,39.0,"Lowry, R. (2020) Clinical Calculator 2: predictive values"
34,,rehabilitation-act-and-other-eeo-laws,,and likelihood ratios. VassarStats: Website for Statistical
35,19.0,"Crotti, N. (2020) BD stops selling COVID-19 antibody test it",,Computation. http://vassarstats.net/clin2.html
36,,"touted in March. MassDevice. Published online May 11, 2020.",40.0,World Health Organization (2017) Quality of HIV testing and
37,,https://www.massdevice.com/breaking-bd-stops-selling-covid-,,"prevention of misdiagnosis. Published online August 29,"
38,,19-antibody-test-it-touted-in-march/,,2017. http://www.who.int/hiv/mediacentre/news/hiv-misdiag-
39,20.0,"Food, U.S. and Administration, Drug (2020) Coronavirus",,nosis-qa/en/
40,,(COVID-19) update: FDA revokes Emergency Use Authorization,41.0,"Wu, F. et al. (2020) Evaluating the association of clinical char-"
41,,for Chembio antibody test. News Release. Published online,,acteristics with neutralizing antibody levels in patients who
42,,"June 16, 2020. https://www.fda.gov/news-events/press-",,"have recovered from mild COVID-19 in Shanghai, China."
43,,announcements/coronavirus-covid-19-update-fda-revokes-,,"JAMA Intern. Med. 180, 1356–1362"
44,,emergency-use-authorization-chembio-antibody-test,42.0,"Long, Q.-X. et al. (2020) Antibody responses to SARS-CoV-2"
45,21.0,US Food and Drug Administration (2020) Revocation of,,"in patients with COVID-19. Nat. Med. 26, 845–848"
46,,EUA200349. https://www.fda.gov/media/140908/download,43.0,"Chen, Y. et al. (2020) A comprehensive, longitudinal analysis of"
47,22.0,Anon (2020) CORRECTION: the FDA has not approved,,humoral responses specific to four recombinant antigens of
48,,a two-minute coronavirus test. Axios. Published online,,SARS-CoV-2 in severe and non-severe COVID-19 patients.
49,,"March 31, 2020. https://www.axios.com/fda-coronavirus-",,"PLoS Pathog. 16, e1008796"
50,,two-minute-testing-kit-bodysphere-a665429d-488d-4edf-,44.0,"Bao, L. et al. (2020) Lack of reinfection in rhesus macaques"
51,,bd36-9180e2a06e4c.html,,"infected with SARS-CoV-2. bioRxiv. Published online May 1,"
52,23.0,Anon (2020) FIND Evaluations of SARS-CoV-2 assays. https://,,2020. https://doi.org/10.1101/2020.03.13.990226
53,,www.finddx.org/covid-19/sarscov2-eval/,45.0,"Chandrashekar, A. et al. (2020) SARS-CoV-2 infection protects"
54,24.0,"Jorfi, M. et al. (2020) Diagnostic technology for COVID-19:",,"against rechallenge in rhesus macaques. Science 369,"
55,,comparative evaluation of antigen and serology-based SARS-,,812–817
56,,"CoV-2 immunoassays, and contact tracing solutions for poten-",46.0,"Liu, W.J. et al. (2017) T-cell immunity of SARS-CoV: Implications"
57,,tial use as at-home products. medRxiv. Published online June,,"for vaccine development against MERS-CoV. Antivir. Res. 137,"
58,,"29, 2020. https://doi.org/10.1101/2020.06.25.20140236",,82–92
59,25.0,"Whitman, J.D. et al. (2020) Test performance evaluation of",47.0,"Yang, L.-T. et al. (2006) Long-lived effector/centralmemory T-cell"
60,,SARS-CoV-2 serological assays. medRxiv. Published online,,responses to severe acute respiratory syndrome coronavirus
61,,"May 17, 2020. https://doi.org/10.1101/2020.04.25.20074856",,(SARS-CoV) S antigen in recovered SARS patients. Clin.
62,26.0,Mass General Brigham Center for COVID Innovation (2020),,"Immunol. 120, 171–178"
63,,Antibody LFA evaluation. https://covidinnovation.partners.,48.0,"Prévost, J. et al. (2020) Cross-sectional evaluation of humoral re-"
64,,org/evaluation/,,sponses against SARS-CoV-2 Spike. bioRxiv. Published online
65,27.0,US Food and Drug Administration (2020) FAQs on testing,,"June 8, 2020. https://doi.org/10.1101/2020.06.08.140244"
66,,for SARS-CoV-2. https://www.fda.gov/medical-devices/,49.0,"Lei, Q. et al. (2020) Antibody dynamics to SARS-CoV-2 in asymp-"
67,,emergency-situations-medical-devices/faqs-testing-sars-cov-2,,tomatic COVID-19 infections. medRxiv. Published online August
68,28.0,"Bendavid, E. et al. (2020) COVID-19 antibody seroprevalence",,"4, 2020. https://doi.org/10.1101/2020.07.09.20149633"
69,,"in Santa Clara County, California. medRxiv. Published online",50.0,"Yu, H. et al. (2020) Distinct features of SARS-CoV-2-specific"
70,,"April 30, 2020. https://doi.org/10.1101/2020.04.14.20062463",,"IgA response in COVID-19 patients. Eur. Respir. J. 56,"
71,29.0,"Gronvall, G. et al. (2020) Developing a National Strategy for",,2001526
72,,"SARS-CoV-2 Serosurveys in the United States, Johns Hopkins",51.0,"Marklund, E. et al. (2020) Serum-IgG responses to SARS-CoV-2"
